https://www.marketscreener.com/quote/stock/DISC-MEDICINE-INC-148741506/news/Disc-Reports-Topline-Results-from-Phase-2-AURORA-Study-of-Bitopertin-in-Patients-with-Erythropoietic-46329250/?utm_source=telegram&utm_medium=social&utm_campaign=share